Advanced solid tumors, or hematological malignancies and normal hepatic function or moderate, or severe hepatic impairment. research hub

A Study of Oral Tazemetostat in Subjects With Moderate and Severe Liver Impairment With Advanced solid tumors or hematological malignancies

This study is looking at a new medicine called tazemetostat for people with advanced cancers. It's especially for those who also have liver problems or healthy livers. We want to see how the medicine works and if it's safe when the liver isn't working as it should.